KEGG   DRUG: Livmoniplimab
Entry
D12793                      Drug                                   
Name
Livmoniplimab (USAN/INN)
Formula
C6486H10050O2048N1708S46
Exact mass
146106.1924
Mol weight
146196.402
Sequence
(Heavy chain)
QVQLVQPGAE VRKPGASVKV SCKASGYRFT SYYIDWVRQA PGQGLEWMGR IDPEDAGTKY
AQKFQGRVTM TADTSTSTVY VELSSLRSED TAVYYCARYE WETVVVGDLM YEYEYWGQGT
LVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF
LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE
QFNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
QEEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK
SRWQEGNVFS CSVMHEALHN HYTQKSLSLS LG
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCQASQSIS SYLAWYQQKP GQAPKILIYG ASRLKTGVPS
RFSGSGSGTS FTLTISSLEP EDAATYYCQQ YASVPVTFGQ GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H140-L214, H153-H209, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'140-L'140, H'153-H'209, H'267-H'327, H'373-H'431, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Monoclonal antibody
Target
LRRC32 [HSA:2615] [KO:K26316]
TGFB1 [HSA:7040] [KO:K13375]
  Pathway
hsa04350  TGF-beta signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Transforming growth factors (RSTK-binding)
    TGFB1
     D12793  Livmoniplimab (USAN/INN)
 Not elsewhere classified
  Signaling molecules
   TGF-beta signaling
    LRRC32
     D12793  Livmoniplimab (USAN/INN)
Other DBs
CAS: 2412004-88-5
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system